SYMPOSIUM: Inflammatory Bowel Disease from Bench to Bedside

New Trends in Advancing Preclinical Candidates

December 13, 2017 - Boston Marriott Cambridge, MA

Crown Bioscience invites you to attend a symposium focusing on the latest advances in Inflammatory Bowel Disease. The symposium will dive into the most relevant topics that are pertinent to this rapidly moving environment.Boston Inflammatory Bowel Disease Symposium

Join your peers in a forum to discuss the disease with the goal of exploring ways to move IBD research forward. 

This symposium is most suited to Inflammation R&D and Preclinical teams from industry, academia, and biomedical research.

Discussion Topics Include: 

  • Introduction to IBD Data Portal
  • Physiology and Pathophysiology of the Human Intestine
  • Strategies for Addressing Unmet Medical Need in Inflammatory Bowel Disease
  • Blocking Leukocyte Trafficking in IBD

Presentations & Speakers

Dr. Bruce Horwitz

Keynote Speaker:

Dr. Bruce Horwitz

Associate Professor of Pediatrics
Harvard Medical School and Attending Physician, Boston Children’s Hospital
Regulation of Mucosal Inflammation by IL-10: Relevance to Very Early Onset IBD

   
Dr. Michelle Solomon
Dr. Michelle Solomon

Senior Study Director
Crown Bioscience Inc.
Moderator

Dr. Magdalena Kasendra
Dr. Magdalena Kasendra

Principal Investigator
Emulate Inc.
Intestine-Chip – A Window into the Physiology and Pathophysiology of the Human Intestine

Dr. Brad McRae
Dr. Brad McRae

Project Director
Immunology Discovery Research AbbVie Inc.
Strategies for Addressing Unmet Medical Need in Inflammatory Bowel Disease

Dr. J. Rodrigo Mora
Dr. J. Rodrigo Mora

Senior Medical Director
Takeda
Blocking Leukocyte Trafficking in IBD: Advantages and Intrinsic Limitations

Michele (Shelley) Trucksis, Ph.D., M.D.
Dr. Michele (Shelley) Trucksis

Executive Vice President and Chief Medical Officer
Seres Therapeutics
SERES-101: A Double Blind, Placebo-Controlled Study of SER-287, a Microbiome Therapeutic, in Subjects with Active Mild to Moderate Ulcerative Colitis

Dr. Jessica R. Allegretti
Dr. Jessica R. Allegretti

Instructor of Medicine
Harvard Medical School
Recurrent Clostridium difficile Infection: Mechanisms of Disease and Emerging Therapeutics


Attendance is free, but seats are limited so reserve your space by submitting the registration form today!

Reserve Your Seat Now!

Reserve Your Seat

Your privacy is important to us.
We'll never share your information.

SHARE THIS